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Abstract
Background: Coracohumeral ligament (CHL) thickening, contracture, and fibroplasia have been identified in
glenohumeral idiopathic adhesive capsulitis (GHIAC). The CHL is the main structure responsible for the range of
motion limitations. Favorable outcomes have been reported with CHL surgical release. Intra-articular glenohumeral
joint corticosteroid infiltrations are utilized to disrupt the inflammatory process and reduce pain in GHIAC. The aim
of this study was to investigate whether the CHL could be accurately targeted with a periligamentous infiltration.
Methods: A convenience sample of 12 unembalmed cadaver shoulders (mean age: 74.5 years, range 66–87 years)
without evidence of previous injury or surgery were utilized in this exploratory double factor feasibility cadaveric
(unguided and ultrasound (US) guided) case series. Two clinicians trained in musculoskeletal infiltration techniques
carried out the infiltrations on each shoulder with colored latex. One clinician infiltrated without guidance, the
other with US-guidance. The injecting clinicians were blinded to the others infiltration procedure and the order was
randomized. An anatomist blinded to the infiltration order performed a shoulder dissection and recorded the
infiltrate location. Percentage calculation for accuracy of infiltration and a chi-square evaluation of the difference
between unguided and US-guided infiltrations was applied.
Results: An accuracy of 75% was achieved for unguided infiltration and 80% for US-guided infiltration techniques.
Chi-squared indicated there was no significant difference (p = 0.82) between the unguided and US-guided
techniques.
Conclusion: US-guided and unguided infiltrations achieved good accuracy targeting the CHL, suggesting
infiltrations can specifically and accurately target the CHL. In vivo investigation using such infiltration techniques are
warranted.
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Background
Glenohumeral idiopathic adhesive capsulitis (GHIAC) is
a common source of pain and disability affecting be-
tween two and 5 % of the general population [1]. Al-
though GHIAC has frequently been suggested to resolve
in 2–3 years, persistent symptoms have been reported on
long term follow up with mild pain and loss of function
in 35% of subjects at 4.4 years (range 2–20 years) [1] and
pain and stiffness in 50% of subjects at 7 years 9 months
(range 2 years 2 months – 11 years) [2].
Bunker [3] suggested that fibroplastic changes in the re-
gion of the rotator interval are pathognomonic for
GHIAC. Thickening, contracture, and fibroplasia of the
coracohumeral ligament (CHL) have been identified in
GHIAC [4–8]. The loss of external rotation is regarded as
a diagnostic finding for GHIAC [3, 9]. Ozaki et al. and
Neer et al. have identified the CHL as the main structure
responsible for ROM limitations in GHIAC [4, 5]. The
CHL is a capsular thickening extending from the lateral
base of the coracoid over the rotator interval and superior
aspect of the shoulder, blending with the capsule and
inserting into the greater and lesser tuberosities [10, 11].
The CHL is taut in External rotation [10]. Favorable out-
comes have been reported in studies targeting the CHL
with a variety of interventions including surgical release
[4, 5, 12], microadhesiolysis [13] and stretching [14]. The
CHL has also been identified as a target structure for
manual therapy in GHIAC [15].
Intra-articular glenohumeral joint infiltrations with corti-
costeroids are frequently used in the treatment of GHIAC
for pain reduction and to disrupt the inflammatory process
[10, 16–20]. They have been found to offer short-term im-
provements, with a rapid decrease in pain and increase in
ROM in the first 6 weeks after treatment [21]. However,
there is no consensus on the site of infiltration [22]. Studies
comparing glenohumeral with subacromial corticosteroid
infiltrations and oral corticosteroids have similar outcomes
[21]. The absence of a superior beneficial effect of cortico-
steroid delivery within the glenohumeral joint may be at-
tributed to an inability to accurately localize the site of
pathology. This has been suggested to be the primary rea-
son for the absence of effective and predictable treatment
outcomes in GHIAC [14]. It would seem unlikely that cor-
ticosteroid delivered intra-articularly would have an optimal
effect on extra-articular CHL inflammation and fibroplastic
processes.
To date, no corticosteroid infiltration study has specif-
ically targeted the CHL for GHIAC. As the CHL is often
surgically released in cases of GHIAC by orthopaedic
surgeons, it would seem imperative to target the liga-
ment using less costly conservative means that could be
easily performed by general healthcare providers.
Therefore, the purposes of this study were to investi-
gate (1) whether the CHL could be accurately targeted
with a periligamentous infiltration by clinicians trained
in musculoskeletal infiltration techniques; and (2)
whether there was added value of ultrasound (US)-
guided infiltration. The long-term goal of this line of re-
search is to investigate cost effectiveness of this infiltra-
tion approach performed by clinicians in patients with
GHIAC. The data and methods of this study have briefly
been presented at the Physiotherapy UK Conference
2018 [23], this article is to present the novel injection
techniques and findings from this study in further detail.
Design
Exploratory double factor cadaveric (unguided and US
guided infiltration) case series.
Methods
Subjects
Six unembalmed cadavers (12 shoulders) from the
Willed body program at the Départment d’anatomie,
Université du Québec à Trois-Rivières were utilized for
this study. Exclusion criteria were evidence of arthro-
plasty, implants, surgery, capsulo-ligamentous or bony
injury to the shoulder. The cadavers were frozen at −
18°c and were thawed for 48 h at room temperature
(16°c), before the infiltrations were performed. The aver-
age age, weight and height of the cadavers were 74.5
years (range, 66–87 years), 57.2 kg (range 40–77.5 kg)
and 165.5 cm (range,157-173 cm), respectively.
Apparatus
Blue and red laboratory grade latex medium (Carolina
Biological Supply Company, Burlington, NC, USA) were
injected with a 1ml syringe and 21-gauge needle, 5%
acetic acid was injected with a 20ml syringe and 25-
gauge needle. An US (LogiqE, General Electric, Missis-
sauga, ON, Canada) was used for imaging during the US
guided infiltrations.
Experimental procedure
The experimental protocol received approval by the sub-
committee ethic board from the Départment d’anatomie,
Université du Québec à Trois-Rivières (SCELERA-17-
01) and carried out in the Gross Anatomy and the Clin-
ical Anatomy Research Laboratories of Départment
d’anatomie, Université du Québec à Trois-Rivières in
June 2017. Two primary health care providers trained in
musculoskeletal infiltration techniques participated in
the study. An extended scope physiotherapist (ESP) spe-
cialized in musculoskeletal assessment, which included
assessment and treatment using manual therapy tech-
niques, exercise and infiltration techniques for 10 years
performed the unguided infiltrations. A recently gradu-
ated physical medicine and rehabilitation specialist ex-
posed to US guided infiltrations during his 5 years of
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residency in physical medicine and rehabilitation per-
formed the US guided infiltrations. Both clinicians
injected each shoulder once. The injecting clinicians
were blinded to each other’s infiltration technique. The
order of infiltration (i.e. US-guided and unguided) was
randomized for each shoulder. Between infiltrations, the
skin surface was cleaned with a tissue to remove traces
of the latex dye so the previous injection site was not
visible to the second injector. The color of latex dye
used by each injecting clinician was also randomized to
blind the dissecting investigator to the injecting clinician.
A 0.05–0.1 ml bolus of latex dye was injected. In order
to solidify the latex dye, the area was infused with 7-10
ml of 5% acetic acid. An anterior shoulder dissection
was carried out by the third investigator, who is an anat-
omist with 15 years of experience, to determine the loca-
tion of the dye boluses. The third investigator was
blinded to the color of dye used by the two injecting cli-
nicians. Direct contact of the latex dye bolus with the
CHL was deemed an accurate periligamentous infiltra-
tion. The latex dye was viscous, adhered to the tissues
and solidified rapidly on contact with acetic acid. Due to
these properties and the small volume delivered in the
injection bolus, it was deemed unlikely that the latex dye
would be displaced by the infused acetic acid or the sub-
sequent dissection.
Unguided infiltration technique
Anatomical landmarks for the unguided infiltration tar-
geting the CHL were determined using US-guided infil-
tration and subsequent dissection in a previous pilot
study. The lateral tip of the coracoid process, superior
aspect of the lesser tuberosity and the lateral tip of the
ventral border of the acromion process were located by
palpation. The infiltration site was located 1 cm lateral
to the lateral tip of the coracoid process along a line
connecting it to the lateral tip of the ventral border of
the acromion process (Fig. 1). The hypodermic needle
was inserted perpendicularly through the skin at this
point. The needle was advanced in a posterior direction
until the resistance (increased stiffness) to the needle de-
tected the CHL and the bolus of latex dye was delivered.
US-guided infiltration technique
Using the US probe oriented in the sagittal plane of the
body, the long head of the biceps was identified in the
rotator cuff interval and the humeral head cartilage deep
in the long axis. The infiltration was in plane with the
US-probe. As the injecting clinician held the US-probe
with his right hand and infiltrated with his left hand on
the right shoulder, the infiltration was performed in a
caudal direction and when it was on the left shoulder in
a cephalad direction. The needle was inserted just super-
ficial to the CHL (Fig. 2).
Statistical analysis
A dichotomous decision of accurate-inaccurate injection
was made. The accuracy calculated as percentages by
dividing the number of accurate infiltrations by the total
number of injections multiplied by 100 for both the un-
guided and US guided infiltrations. The numbers of ac-
curate and inaccurate injections for both the unguided
and US guided infiltrations were assessed for statistical
significance using Chi-Square analysis.
Fig. 1 Bony landmarks for unguided Coracohumeral ligament
periligamentous injection needle placement of a right shoulder. CP:
Coracoid Process; AP: Acromion Process. The needle is inserted 1cm
from the lateral tip of the Coracoid Process along a line connecting
the lateral tip of the Coracoid Process with the lateral tip of the
ventral border of the Acromion Process: dotted line
Fig. 2 Ultrasound scan guided Coracohumeral ligament
periligamentous injection of a right shoulder showing
coracohumeral ligament: white arrow heads; HH: Humeral head; CP:
Coracoid process; injecting needle: blue arrow heads. Transducer
placement over the anterior superior aspect of the shoulder, with
the coracohumeral ligament in the long axis
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Results
The bolus of latex dye was in contact with the CHL in 9
of the 12 unguided infiltrations and 8 of the 12 guided in-
jections (Fig. 3). The accuracy of the unguided infiltrations
was 75% and US-guided infiltrations was 67%. A Chi-
square test of independence was conducted to assess
whether infiltration would be more accurate with un-
guided or US-guided infiltrations. Yates correction was
deemed necessary due to the small number of subjects
and more than 20% of the expected frequency cells had
counts of 5 or less. For α = .05 the accuracies of unguided
and US-guided injections were not significantly different.
Χ2 (Yates correction) (1, Ν=24) = 0.00, p = 1.00.
Whereas the ESP had previously participated in a pilot
study exploring the technique for infiltrating the CHL, the
physiatrist had not participated in the pilot study and al-
though experienced in US-guided injections, was unfamiliar
with this particular injection technique. The first 2 US-
guided infiltrations were not accurate, this was attributed to
lack of experience with this injection technique and some
initial technical difficulties with an unfamiliar US machine.
Therefore, the results from first 2 US guided infiltrations
were discarded. Of the remaining 10 US-guided infiltrations
8 were in contact with the CHL, giving an accuracy of 80%.
Again, a Chi-square test of independence with Yates cor-
rection showed the accuracies of unguided and US-guided
infiltrations were not significantly different. Χ2 (Yates cor-
rection) (1, Ν=22) = 0.054, p = 0.82 (Table 1).
For the 9 accurate unguided infiltrations, in 7 the
bolus was in contact with the CHL anterior surface and
2 were in contact with the posterior surface. In all 8 of
the accurate US-guided infiltrations, the bolus was in
contact with the anterior surface of the CHL.
In the unguided infiltrations that were not accurate,
the bolus was located intra-articular in the glenohumeral
joint in 2 specimens and posterior to the subscapularis
muscle in the third attempt. For the inaccurate US-
guided infiltrations the bolus of latex was located intra-
articular in the glenohumeral joint.
Discussion
This is the first study to investigate the accuracy and
feasibility of US-guided and unguided periligamentous
CHL infiltrations. With an overall accuracy of 75% for
unguided infiltrations and 80% for US guided infiltra-
tions would suggest that the CHL could be targeted suc-
cessfully with this technique in subsequent trials in live
subjects with GHIAC. If the CHL can be successfully
targeted using feedback (resistance) from the needle in
cadavers without obvious shoulder pathology, then the
grossly thickened rubbery scar tissue of the CHL in
GHIAC [6] should provide increased feedback and assist
in accurate placement of the infiltration bolus in these
subjects. For intra-articular glenohumeral joint injections
the accuracy determined by radiogram of US-guided in-
jections has been reported at 90% and unguided injec-
tion at 76.19% [24]. In this study targeting the CHL, US-
guided injections were slightly less accurate at 80% while
the unguided injections achieved similar accuracy at
75%. The targeting of a thin membranous like structure
like the CHL could be regarded as technically more de-
manding than a relatively large joint space. Despite the
expected difficulty with this injection it has demon-
strated good accuracy for both US guided and unguided
injections.
The good accuracy achieved with the unguided infiltra-
tions, suggests that a pragmatic approach to these infiltra-
tions can be taken. This intervention could be taken by
primary care providers without recourse to onward referral
to a consultant or for infiltration under guidance. This
should offer a timely intervention with reduced delay and
Fig. 3 Showing latex dye location following US-guided and
unguided infiltrations for a right shoulder, with the blue latex dye
following unguided injection in contact and deep to the
Coracohumeral ligament and red dye following US-guided
infiltration in contact with the anterior surface of the Coracohumeral
ligament. CHL: Coracohumeral Ligament; CP: Coracoid Process; GHC:
Glenohumeral joint Capsule
Table 1 Descriptive data: accurate, not accurate, total and





not accurate 2 3
Totals 10 12
Percentage Accurate 80% 75%
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costs. Note that the inaccuracy of the first 2 US-guided in-
filtrations was attributed to technical difficulties with an un-
familiar US device and lack of familiarity with this
particular infiltration technique. In the subsequent US-
guided infiltrations, the physiatrist then reached 80% accur-
acy, indicating that US-guided learning occurs quickly for
this technique, but necessitates practice. Pre-trial training
would have prevented these 2 injections being discarded. A
cross over study could have been utilized to examine for
the effect of levels of experience on injections accuracy.
For the accurate infiltrations, the majority of the injected
boluses were in contact with the anterior surface of the
ligament, and two were in contact with its posterior as-
pect. It is difficult to predict if there is any difference in
clinical efficacy with the anterior or posterior location of
the bolus. As the rotator interval is also involved in
GHIAC [3, 7], it may be expected that delivery deep to the
CHL is more effective. For the US guided infiltrations
deemed inaccurate and not in contact with the CHL the
bolus of latex dye was located intra-articular within the
glenohumeral joint. Three unguided infiltrations were
deemed inaccurate. In two of these, the latex dye bolus
was located within the glenohumeral joint. In the third,
the bolus was delivered deep to the subscapularis muscle.
Those infiltrations delivered intra-articular within the gle-
nohumeral joint would normally be considered effective
for GHIAC. Infiltrations delivered between the glenohum-
eral joint capsule and the CHL would lie in the rotator
interval, a structure implicated in GHIAC. These infiltra-
tions would be considered clinically effective, especially in
the light of recent work on collagenase infiltrations with
positive outcome attributed to the effect on the rotator
interval and the CHL [25].
It has been suggested that infiltration of ligaments is
inappropriate as it may lead to rupture [26]. However,
the evidence against corticosteroid targeting ligaments is
largely anecdotal [27]. The CHL is usually a thin fold of
the glenohumeral capsule. It is lined by synovium on its
anterior surface and has little resemblance to a true liga-
ment [28]. Concerns about CHL rupture are further
allayed by the fact that it is frequently targeted for re-
lease by orthopaedic surgeons [4, 5, 12] and torn by ma-
nipulation under anaesthesia [6]. Additionally, there may
be concerns that the long head of biceps (LHB) tendon
may be compromised by an inaccurate infiltration tar-
geting the CHL. During dissection, the colored dye nee-
dle tracks through the tissue were clearly visible in many
of the injected shoulders. These needle tracks were not
in proximity to the LHB. The upper, middle and lower
trunks of the brachial plexus, cephalic vein, axillary ar-
tery and vein are all located medially and inferiorly to
the coracoid process [29, 30] and therefore remote from
the infiltration. A similar infiltration approach has been
utilized to target the glenohumeral anterior capsule with
collagenase infiltration without serious complications
[25]. As intraarticular corticosteroid infiltration is advo-
cated in the treatment of GHIAC and may be chondro-
protective [31–33], this risk is not incurred. Essentially
infiltration targeting the CHL with corticosteroid by an
anterior approach may be regarded as a safe infiltration.
Inaccurate corticosteroid placement can compromise
therapeutic outcomes of infiltration therapy [34, 35]. It
was therefore imperative to demonstrate that the CHL
could be accurately and consistently targeted for future
studies and therapeutic treatments. The good accuracy
obtained with the unguided infiltrations suggests that
this technique can easily be carried out in primary care.
Although fluoroscopic and US-guided infiltrations have
become the gold standard for accuracy, guided infiltra-
tions are frequently unavailable in primary care and on-
ward referral might result in delay and increased
expense. However, it should definitely be considered
after poor outcomes with previous unguided infiltrations
[34, 35]. As the GHIAC response to corticosteroid infil-
trations is better in the early stages [18], early infiltration
in the primary care setting could shorten the duration of
the symptoms and disability with a significant value in
terms of reduced morbidity and costs to both the indi-
vidual and the community [36].
Limitations of the study are the limited numbers of ca-
daver subjects and also the limited number of injecting
clinicians that participated. However it is not uncom-
mon for cadaveric injection studies to be based on a lim-
ited number of subjects and a limited number of
injecting clinicians [37–39]. A further limitation is the
varied levels of experience of the injecting clinicians and
specifically varied level of experience with this technique,
resulting in the first 2 US-guided injections been dis-
carded. This could have been avoided with pre-trial
training. A cross over study could have been utilized to
examine for the effect of levels of experience on the ac-
curacy of injections.
Future studies are needed to progress to in vivo infil-
trations in subjects with GHIAC including reliability
studies with these infiltrations being carried out by other
clinicians and studies of efficacy with randomized con-
trolled trials.
Conclusion
This feasibility cadaveric case series demonstrated that
both US guided and unguided periligamentous injections
targeted the CHL with good accuracy. This may repre-
sent a more specific option for GHIAC treatment than
intra-articular infiltrations. Further studies are needed to
progress to in vivo infiltrations in subjects with GHIAC
and to investigate the reliability of these infiltrations
when carried out by other clinicians.
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